Me. Fabregat et al., AUTOANTIBODIES AGAINST MITOCHONDRIAL GLYCEROPHOSPHATE DEHYDROGENASE IN PATIENTS WITH IDDM, Diabetes research and clinical practice, 38(2), 1997, pp. 115-121
The mitochondrial enzyme FAD-linked glycerophosphate dehydrogenase (mG
DH) plays a key role in the recognition of D-glucose as a stimulus for
insulin release from the pancreatic islet B-cell. This study reveals
that autoantibodies against this enzyme are not uncommonly found in pa
tients with insulin-dependent diabetes mellitus (IDDM) examined at the
onset of the disease. Antibodies reacting with a recombinant mGDH fra
gment product were observed in the serum of four out of 15 type-1 diab
etics, but in none of 15 control subjects. The serum of patients posit
ive for the recombinant mGDH fragment also recognized native mGDH in a
rat testis extract, provided that the enzymatic protein was first exp
osed to an anti-mGDH rabbit serum. Antibodies against mGDH were also f
ound in four out 12 patients with autoimmune thyroiditis. These findin
gs reveal that a mitochondrial enzyme, that represents an essential co
mponent of the islet B-cell glucose-sensing device, may act as an anti
genic determinant in patients with IDDM or other autoimmune diseases.
(C) 1997 Elsevier Science Ireland Ltd.